Gabapentin
Product Images NDC 67296-1777

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67296-1777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

67296 1777 3

The label for Gabapentin 300mg capsules, showing a 30-capsule package. It is marked Rx only with lot number 180281X1 and expiration date 07/23. Manufactured by ScieGen Pharmaceuticals Inc, Hauppauge NY, and distributed by RedPharm Drug, Eden Prairie, MN. The label includes storage instructions for controlled room temperature (20-25°C).*

FDA Label Image

Label (67296 1777)

Label for Gabapentin 300 mg capsules with a total count of 20 capsules. The label includes the NDC number 67296-1777, indicates prescription use only (Rx Only), and displays an expiration date of October 2021. Manufacturer information lists Sciegen Pharmaceuticals Inc., Hauppauge, NY, and distributor details show Redpharm Drug, Eden Prairie, MN. Storage instructions specify controlled room temperature (20-25°C or 68-77°F).*

FDA Label Image

Gabapentin Capsules, Usp 100 mg (1,000 capsules label)

Label of Gabapentin Capsules, USP 100 mg by ScieGen Pharmaceuticals Inc., displaying an NDC of 50228-179-10. The label indicates a quantity of 1,000 capsules and includes storage instructions, dosing notes, and a barcode. The label also states 'Rx only' and has a notice 'NO VARNISH'.*

FDA Label Image

Gabapentin Capsules, Usp 100 mg-100 Capsules Label (Gabapentin 100mg 100cap)

Gabapentin Capsules USP 100 mg label showing key information including the NDC number 50228-179-01, quantity of 100 capsules, and manufacturer ScieGen Pharmaceuticals Inc. The label includes storage instructions and a barcode. The right side features the text 'NO VARNISH' in orange.*

FDA Label Image

Gabapentin Capsules, Usp 100 mg-30 Capsules Label (Gabapentin 100mg 30cap)

Label for Gabapentin Capsules USP, 100 mg strength, with a quantity of 30 capsules. The label includes storage instructions, dosage advisory, and states the product is Rx only. It shows the NDC 50228-179-30 and is manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

Gabapentin Capsules, Usp 100 mg-500 Capsules Label (Gabapentin 100mg 500cap)

Gabapentin Capsules USP 100 mg label from ScieGen Pharmaceuticals Inc. The label shows the product name, strength, dosage form, and packaging size of 500 capsules. It includes storage instructions, prescribing information, a barcode, and notes that it's Rx only. The label also states "NO VARNISH" on the right edge and provides manufacturer and revision details.*

FDA Label Image

Gabapentin Capsules, Usp 300 mg (100 capsules label)

Gabapentin Capsules, USP 300 mg bottle label from ScieGen Pharmaceuticals Inc. The label indicates Rx only, bottle contains 100 capsules, includes storage and safety information, manufacturer details, and a bar code. Background is white with purple and blue text and graphics.*

FDA Label Image

Gabapentin Capsules, Usp 300 mg (30 capsules label)

Label for Gabapentin capsules, USP 300 mg. The label includes dosage details, storage instructions, and a barcode. It indicates a 30-capsule package with Rx only. Manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY. The product NDC on the label is 50228-180-30.*

FDA Label Image

Gabapentin Capsules, Usp 300 mg (500 capsules label)

Label for Gabapentin Capsules, USP 300 mg by ScieGen Pharmaceuticals Inc. The label states 'Rx only' and indicates a bottle count of 500 capsules. It includes storage instructions and a barcode, with the phrase 'NO VARNISH' on the right side. The label shows the NDC 50228-180-05 and manufacturing details from Hauppauge, NY.*

FDA Label Image

Gabapentin Capsules, Usp 400 mg (100 capsules label)

Label for Gabapentin Capsules, USP 400 mg by ScieGen Pharmaceuticals, Inc. It shows the drug name, strength, dosage form, quantity of 100 capsules, and instructions such as storage temperature and child-resistant container requirement. The label includes a barcode and manufacturer information, with a note stating 'NO VARNISH'.*

FDA Label Image

Gabapentin Capsules, Usp 400 mg (30 capsules label)

Gabapentin Capsules, USP 400 mg label from RedPharm Drug, Inc. This label includes dosage strength (400 mg), storage instructions, quantity (30 capsules), and manufacturer information (ScieGen Pharmaceuticals, Inc.). It also shows a barcode, prescribing note, and a revision date of 12/17.*

FDA Label Image

Gabapentin Capsules, Usp 400 mg (500 capsules label)

Gabapentin Capsules, USP 400 mg label from ScieGen Pharmaceuticals Inc. The label includes the prescription status (Rx only), a package size of 500 capsules, storage instructions, and a barcode. The label also indicates the product is child-resistant and states 'NO VARNISH' on the right side.*

FDA Label Image

Gabapentin Tablets, Usp 600 mg (100 Tablets label)

Gabapentin Tablets, USP 600 mg bottle label from ScieGen Pharmaceuticals Inc. The label states Rx only and indicates a 100 tablet count. It includes storage, dosage, and safety information, along with a barcode and manufacturer details. "NO VARNISH" is printed in orange on the side panel.*

FDA Label Image

Gabapentin Tablets, Usp 600 mg (30 Tablets label)

Gabapentin Tablets, USP 600 mg label for a bottle containing 30 tablets. The label includes dosage strength and quantity, with storage instructions and dispensing information. It shows the product NDC 50228-177-30 and notes the manufacturer as ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

Gabapentin Tablets, Usp 600 mg (500 Tablets label)

Gabapentin Tablets, USP 600 mg tablet bottle label showing 500 tablets count. The label includes the NDC number 50228-177-05, Rx only statement, manufacturer ScieGen Pharmaceuticals Inc., and storage instructions. A barcode and a 'NO VARNISH' warning are also visible.*

FDA Label Image

Gabapentin Tablets, Usp 800 mg (100 Tablets label)

Gabapentin Tablets USP 800 mg label showing 100 tablets per bottle. The label includes directions for storage between 20 to 25°C, dosage instructions, tamper-evident warnings, and manufacturer information for ScieGen Pharmaceuticals, Inc. The label also states 'Rx only' and highlights 'NO VARNISH' vertically on the right side.*

FDA Label Image

Gabapentin Tablets, Usp 800 mg (30 Tablets label)

Label for Gabapentin Tablets, USP, 800 mg strength, showing a package size of 30 tablets. The label includes storage instructions, dosage directions referencing accompanying prescribing information, and a barcode. The label lists ScieGen Pharmaceuticals, Inc. as the manufacturer. The NDC displayed is 50228-178-30.*

FDA Label Image

Gabapentin Tablets, Usp 800 mg (500 Tablets label)

Gabapentin Tablets, USP 800 mg label for a 500 tablet package from ScieGen Pharmaceuticals Inc. The label includes dosage form and strength, prescription-only status, storage instructions, and manufacturing information with a barcode and NDC 50228-178-05. The right side states NO VARNISH.*

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain score over 8 weeks comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks (baseline to 8), and the y-axis represents mean pain score from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period, with gabapentin showing a consistent decrease in pain score compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain score over 7 weeks comparing placebo and gabapentin at doses of 1800 mg/day and 2400 mg/day. The x-axis represents weeks including a 3-week dose titration period followed by a 4-week fixed dose period, and the y-axis shows mean pain scores from 0 to 10. Gabapentin groups show a decrease in pain scores over time compared to placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the percentage of responders between placebo (PBO) and Gabapentin (GBP) at different dosages in two studies. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg. Study 2 shows 14% responders for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated for GBP groups versus placebo.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

An instructional formula diagram showing the calculation for creatinine clearance (CLCr). The formula includes age in years, weight in kilograms, serum creatinine in mg/dL, and a factor of 0.85 for female patients, representing an adjustment in the calculation.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin showing a cyclohexane ring bonded to an aminoethyl and carboxymethyl group.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

A scatter plot showing the percent difference on the y-axis versus daily dose in mg on the x-axis for Gabapentin. The chart compares data points from three studies labeled a, b, and c, with doses at 600, 900, 1200, and 1800 mg, displaying variations in percent difference among the studies at each dose level.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.